This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.
Company Filing History:
1 out of 834,350 Years Active: 2004
Title: Innovations in Oocyte Activation by David Epel
Introduction
David Epel is a notable inventor based in Carmel, CA (US). He has made significant contributions to the field of reproductive biology, particularly in the modulation of oocyte activation. His work has implications for both fertility treatments and contraceptive methods.
Latest Patents
Epel holds a patent titled "Methods for modulation of oocyte activation." This patent highlights the necessity of nitric oxide synthase and nitric-oxide-related bioactivity for the activation of an oocyte during fertilization. The methods described in the patent provide ways to modulate oocyte activation by adjusting nitric oxide levels. Specifically, the addition of nitric oxide synthase, its activators, donors, or other compounds that increase nitric oxide levels can enhance oocyte activation during fertilization. Conversely, the administration of nitric oxide synthase inhibitors can block oocyte activation when contraception is desired.
Career Highlights
Throughout his career, David Epel has focused on the intersection of biology and technology, leading to innovative solutions in reproductive health. His research has paved the way for advancements in understanding how oocytes can be activated and manipulated, which is crucial for both fertility and contraceptive applications.
Collaborations
Epel has collaborated with notable colleagues such as Richard Kuo and Gregory T Baxter. These partnerships have contributed to the depth and breadth of his research, enhancing the impact of his findings in the scientific community.
Conclusion
David Epel's work in the modulation of oocyte activation represents a significant advancement in reproductive biology. His innovative approaches have the potential to influence both fertility treatments and contraceptive methods, showcasing the importance of his contributions to the field.